Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

U.S. Federal Court Determines Hytera Continues to Use Motorola Solutions’ Stolen Trade Secrets

(NYSE:MSI) CHICAGO--(BUSINESS WIRE)--Motorola Solutions, Inc. (NYSE: MSI) supports the recent ruling from the U.S. District Court for the Northern District of Illinois (the “District Court”) that d...

When is the litigation likely to be resolved and what are the potential long‑term financial implications for both Motorola Solutions and Hytera? What effect could the injunction on Hyperm’s use of Motorola’s trade secrets have on the competitive landscape of the DMR market? How will Motorola Solutions’ stock react to the court ruling and potential future damages?
Symbol: MSI
Lawsuits
13 days ago
Read more businesswire

Orezone Gold Provides Market Update Following Government Meeting

(ORE) VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE | ASX: ORE | OTCQX: ORZCF) (“Orezone” or “Company”) announces that the Company has met in ...

What impact might this clarification have on Orezone’s valuation and investor sentiment compared to peer miners operating in similar jurisdictions? Does the government's specific request to buy equity in another local project signal any broader regulatory or political risk for Orezone's existing operations? How will the reaffirmation that Burkina Faso won't take an equity stake affect Orezone's capital allocation and potential dilution risk?
Symbol: ORE
Regulation
13 days ago
Read more globenewswire

Oncolytics Biotech® Provides Updated Clinical Safety Data for Pelareorep, Including Across Multiple Gastrointestinal Tumors

(NASDAQ:ONCY) Data continue to demonstrate a favorable safety profile for pelareorep across multiple indications and in combination with multiple treatments Updated clinical data now account for ov...

When is the next significant data read‑out or milestone (e.g., efficacy results from the GOBLET study) that could further impact the company’s market valuation? What does the expanded safety profile across >300 GI cancer patients mean for pelareorep’s competitive positioning and potential regulatory approval timeline compared to rival therapies? How will the updated safety data for pelareorep influence Oncolytics' short‑term stock price and analyst earnings estimates?
Symbol: ONCY
Clinical trials
13 days ago
Read more prnewswire

C3is Inc. reports second quarter and six months 2025 financial and operating results

(NASDAQ:CISS) ATHENS, Greece, Sept. 02, 2025 (GLOBE NEWSWIRE) -- C3is Inc. (Nasdaq: CISS) (the “Company”), a ship-owning company providing drybulk and tanker seaborne transportation services, ann...

Did the company provide any guidance or outlook for the remainder of 2025, and what are the implications for the stock valuation? What changes in fleet utilization, charter rates, or freight market conditions are reflected in the results, and how might they affect future earnings? How did C3is' Q2 earnings and cash flow compare to analyst expectations and prior periods?
Symbol: CISS
Earnings
13 days ago
Read more globenewswire